Combined Effect of Laser Acupuncture and Electroacupuncture in Knee Osteoarthritis Patients

January 27, 2021 updated by: Chang Gung Memorial Hospital

Combined Effect of Laser Acupuncture and Electroacupuncture in Knee Osteoarthritis Patients: a Protocol for a Randomized Controlled Trial

Background:

Knee osteoarthritis (KOA) is a common degenerative joint disorder affected 250 million people globally. It can not only result in disability, but also associated with cardiovascular disease and mortality. The most common treatment for KOA is non-steroidal anti-inflammatory drug. However, the effect of analgesic is limited and may complicate with side effect. Hence, many patients search for complementary and alternative medicine. Acupuncture is one of the most popular complementary treatment with good analgesic effect and less side effect. Electroacupuncture (EA) or laser acupuncture (LA) was reported effective in pain control in knee osteoarthritis patients. However, there is no study about combination effect of EA and LA.

Methods:

This protocol is a randomized controlled trial investigating the combination effect of EA and LA on KOA. Fifty participants diagnosed KOA with aged more than 50 years old and knee pain more than 3 months were recruited and randomly assigned to the experimental group (EA plus LA) or sham group (EA plus LA without laser output) in clinical research center. The subjects will undergo EA plus LA treatment thrice a weeks for 4 weeks. The experimental group will receive acupuncture at GB33, GB34, SP9, SP10, and ST36 with transcutaneous electrical nerve stimulator on the GB34+33 and SP9+10., and the LA deliver 6 Joule of energy at EX-LE5, ST35, and BL40. The subjects in sham group will receive the same way but the LA is without any laser output. Outcome measurement will include visual analogue scale (VAS), Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), Knee injury and osteoarthritis outcome (KOOS), body composition analysis, knee range of motion test, muscle stiffness test, standing on one foot test, and the 30-second chair stand test before intervention and after 4 weeks intervention. The result will be analyze and compared between the experimental group and sham group using the paired t test and one-way analysis of variance.

Objectives:

The aim of this protocol is to investigate the combination effect of EA and LA in KOA patients.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaohsiung, Taiwan, 833
        • Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • VAS more than 3 point when daily activity
  • Kellgren-Lawrence Grading Scale grade 1 to 3 on knee X-ray
  • Provided informed consent

Exclusion Criteria:

  • History of knee arthroplasty, traumatic injury related joint deformity,
  • Body mass index more than 35
  • pacemaker insertion, photosensitivity
  • who had undergone intra-articular injection or acupuncture in recent one month
  • other factors that may affect the evaluation of the outcome, such as psychiatric disorder or moderate mental retardation etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
True LA with EA

The LA is using a gallium aluminum arsenide LaserPen (maximal power, 150 mW; wavelength, 810nm; area of probe, 0.03cm2; power density, 5W/cm2; pulsed wave; RJ-Laser, Reimers & Janssen GmbH, Waldkirch, Germany). The LA treatment will be applied to EX-LE5, ST35, and BL40 for 80 seconds, under power 150mW, to deliver a total treatment dose of 6 Joule/ cm2.

The EA is the combination of acupuncture and transcutaneous electrical nerve stimulator. The transcutaneous electrical nerve stimulator is produced by Ching Ming Medical Device Company. This machine is verified by Department of Health in Taiwan, with the ID number 001147. We perform acupuncture on GB33, GB34, SP9, SP10, and ST36.

Sham Comparator: Group B
Sham LA with EA
Sham LA is using the same appearance of LaserPen without energy output to perform the same acupoint as above description. Both of the LaserPen in two groups are labeled with A and B, one of them is revised by the company to become the sham LA. The outward of both LaserPen are the same and our physician does not know which one is the real.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Visual Analog Score
Time Frame: Through study completion, an average of 4 weeks
Visual Analog Score for pain during activity; change from baseline at 4 weeks; scoring from 0 to 10, and the higher scores indicate the worse condition
Through study completion, an average of 4 weeks
Use of analgesics
Time Frame: Through study completion, an average of 4 weeks
Frequency of analgesics
Through study completion, an average of 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of the score of Western Ontario and McMaster Universities Arthritis Index
Time Frame: Through study completion, an average of 4 weeks
Questionnaires for the function in patients with OA knee; change from baseline at 4 weeks; scoring from 0 to 68, and the higher scores indicate the worse condition
Through study completion, an average of 4 weeks
Change of the percentage of Knee Injury and Osteoarthritis Outcome Score
Time Frame: Through study completion, an average of 4 weeks
Questionnaires for the function in patients with OA knee; change from baseline at 4 weeks; scoring from 0 to 100 percentage, and the higher percentage indicates the better condition
Through study completion, an average of 4 weeks
Change of the muscle stiffness of quadriceps
Time Frame: Through study completion, an average of 4 weeks
The value is measured by Myoton Digital Palpation Device; change from baseline at 4 weeks
Through study completion, an average of 4 weeks
Change of the angle of knee range of motion
Time Frame: Through study completion, an average of 4 weeks
The range between flexion and extension of the knee; change from baseline at 4 weeks
Through study completion, an average of 4 weeks
Change of the minutes of standing on one foot test
Time Frame: Through study completion, an average of 4 weeks
The patient stands on one foot with hands on hips and eye opening. The time that the patient can stand on one foot was recorded; change from baseline at 4 weeks
Through study completion, an average of 4 weeks
Change of the times of 30-second chair stand test
Time Frame: Through study completion, an average of 4 weeks
The patient sits on the chair with bilateral feet stepping on the ground and hands cross beyond chest. Then he/she stands up and then sits down. The definition of once is completing one standing up and then sitting down. The number of times that the patient could stand up and then sit down within 30 seconds; change from baseline at 4 weeks.
Through study completion, an average of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 3, 2019

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

December 1, 2019

First Submitted That Met QC Criteria

December 4, 2019

First Posted (Actual)

December 6, 2019

Study Record Updates

Last Update Posted (Actual)

January 28, 2021

Last Update Submitted That Met QC Criteria

January 27, 2021

Last Verified

August 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Laser Acupuncture

Subscribe